![Bilal Arif](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bilal Arif
Geschäftsführer bei
KALVISTA PHARMA
Vermögen: 293 497 $ am 31.05.2026
Profil
Bilal Arif currently works at KalVista Pharmaceuticals, Inc., as Chief Operating Officer from 2025.
Mr. Arif also formerly worked at Sarepta Therapeutics, Inc., as Chief Technical Operations Officer & Executive VP from 2022 to 2025, Momenta Pharmaceuticals, Inc., as Vice President-Technical Operations from 2017 to 2019, and Shire Plc, as Vice President-Technical Operations from 2015 to 2017.
Mr. Arif received his undergraduate degree from McGill University, graduate degree from Tufts University, Masters Business Admin degree from Instituto de Empresa SL, and undergraduate degree from Western New England University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.08.2025 | 16.424 ( 0,02 % ) | 293 497 $ | 31.05.2026 |
Aktive Positionen von Bilal Arif
| Unternehmen | Position | Beginn |
|---|---|---|
| KALVISTA PHARMA | Geschäftsführer | 06.10.2025 |
Ehemalige bekannte Positionen von Bilal Arif
| Unternehmen | Position | Ende |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.08.2025 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2019 |
| SHIRE | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2017 |
Ausbildung von Bilal Arif
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
62
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tufts University
 Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western New England University
 Western New England University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instituto de Empresa SL
 Instituto de Empresa SL Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
